The Swiss Federal Supreme Court decided on the dispute about “Commune de Champagne PDO” in two judgements (December 23, 2022, 2C_407/2021; March 22, 2022, 2C_381/2021). The Canton de Vaud had introduced, in January 2021, a PDO “Commune de Champagne” for
Tags :Jürg Frick
Today, VAT Group has signed a syndicated term and multicurrency revolving credit facilities agreement with a syndicate of eleven banks, led by UBS Switzerland, to replace its current agreements that are due to expire in 2023.
Accelleron Industries and Turbo Systems Schweiz have entered into a CHF 450 m credit facilities agreement with Credit Suisse Switzerland as mandated lead arranger, agent and original lender. Based in Baden, Accelleron is a renowed company
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
On September 23, 2022, Roche Kapitalmarkt issued CHF 800 million Bonds guaranteed by Roche Holding. Credit Suisse and UBS acted as lead managers. The bonds will be listed on the SIX Swiss Exchange. The transaction consists of a
Homburger has acted as counsel to Dätwyler Holding and Datwyler Parco Holdings in connection with a Swiss law governed USD 175 m credit facility arranged by UBS Switzerland for the purpose of refinancing certain indebtedness
Kering completed the sale of Sowind Group, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to Sowind’s management. The luxury Group has supported the two Houses in their development, strengthened their positioning
Sonova Holding, providers of hearing aid solutions, has completed the placement of CHF 450 million Bonds governed by Swiss law. Application will be made for the Bonds to be listed on the SIX Swiss Exchange. The
Aris Gold Corporation has entered into a definitive agreement with MDC Industry Holding Company, a wholly owned subsidiary of the Abu Dhabi based investment company Mubadala Investment Company, whereby Aris Gold would acquire a 20% joint
VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio
